| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-22 |
| filingDate |
2007-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81715413d1266a6097576180ad9fbcf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd185c73e23b0e072eed818039e85121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5ddb5ed037f093a30eadd6090fae829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8deb5aff42a1826cab291529dd4ccc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_830d52d0ff177df1d7a788f1fa8b680b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c30530c8602dda687ef1ec9e1e5c87b7 |
| publicationDate |
2008-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2663965-A1 |
| titleOfInvention |
Pyrazolopyrimidine derivative and use thereof as an anticancer agent |
| abstract |
[PROBLEMS] To provide a novel compound capable of inhibiting the activity of HSP90, particularly a novel compound capable of inhibiting the chaperon protein function of HSP90 and having an anti-tumor activity. [MEANS FOR SOLVING PROBLEMS] A pyrazolopyrimidine compound represented by the formula (1) having various substituents, which is capable of inhibiting the ATPase activity of HSP90 and has an anti-tumor activity; an HSP90 inhibitor comprising the compound represented by the formula (1); a pharmaceutical agent comprising the compound represented by the formula (1); an anti-cancer agent comprising the compound represented by the formula (1); a pharmaceutical composition comprising the compound represented by the formula (1); a method for the treatment of cancer by using the compound represented by the formula (1); and others. (1) |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010114905-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010249110-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8343983-B2 |
| priorityDate |
2006-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |